Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors [Phase 1]

View source ↗

Summary

A phase 1 trial evaluating the safety of combining avelumab with lenvatinib in children with central nervous system tumors; the study is active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)
  • LENVIMA (lenvatinib)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Central Nervous System Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING